Safety, Pharmacokinetics, and Efficacy Study of NB-001 to Treat Recurrent Herpes Labialis

Completed · Phase 2

Conditions studied: Herpes Labialis

In brief

Purpose of this study is to determine the safety and efficacy of topical applications of NB-001 as compared to placebo for the treatment of recurrent herpes labialis.

Key facts

Study ID
NCT00453401
Run by
NanoBio Corporation
People needed
1000
Starts
2007-02-01
Expected to finish
2007-12-01
Last updated by the study team
2008-05-30

Who can join

Age: 18 and older, up to 80. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.